From AI Prediction to Experimental Validation of Food-Derived Bioactives: A Critical Review
FOOD REVIEWS INTERNATIONAL, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Derleme
- Basım Tarihi: 2026
- Doi Numarası: 10.1080/87559129.2026.2757756
- Dergi Adı: FOOD REVIEWS INTERNATIONAL
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, ABI/INFORM, CAB Abstracts, Compendex, Food Science & Technology Abstracts, Hospitality & Tourism Complete, Hospitality & Tourism Index, Academic Search Ultimate (EBSCO), Natural Science Collection (ProQuest), Biomedical Reference Collection: Corporate Edition (EBSCO), Engineering Source (EBSCO)
- Bursa Uludağ Üniversitesi Adresli: Evet
Özet
Unlike reviews that concentrate on retrospective AI model accuracy, this critical review evaluates whether computationally prioritized candidates progress toward substantiated food functionality. It combines an appraisal of computational and biotechnological discovery workflows with an explicit validation ladder, comparing the highest experimentally documented stage reached in 12 illustrative AI-assisted peptide, food-related small-molecule, natural-product, or food-delivery studies (). The critical contribution is to distinguish computational ranking and isolated assay activity from nutritional translation, particularly digestion, food-matrix exposure, animal validation, and human efficacy. Foods contain a large, only partially characterized chemical space, and artificial intelligence (AI) is increasingly used to prioritize candidate bioactives. This review critically examines AI-driven discovery of functional food ingredients and bioactive compounds across the discovery-to-translation continuum. We discuss the data landscape supporting computational discovery, including food composition, omics, and microbiome resources, together with challenges in annotation, standardization, and integration. Major computational approaches, including machine learning, quantitative structure-activity relationship modeling, deep learning, molecular docking, natural language processing, knowledge graphs, and generative design, are reviewed alongside biotechnological platforms for candidate generation and production. Applications in cardiometabolic health, oxidative stress and inflammation, and gut health are considered. Particular emphasis is placed on a structured validation pathway encompassing chemical confirmation, biological activity, gastrointestinal stability, food-matrix bioaccessibility, intestinal transport, microbiota-mediated transformation, animal and human evidence, safety, and technological feasibility. Current AI-assisted discoveries remain concentrated at early validation stages; predicted bioactivity should therefore be treated as a hypothesis rather than evidence of functional efficacy. Finally, we outline methodological, ethical, regulatory, and data requirements for closed-loop discovery frameworks integrating computational prediction with experimental validation.